| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Sunitinib |
| Appearance | White to light yellow Powder |
| CAS No. | 557795-19-4 |
| MF | C22H27FN4O2 |
| MW | 402.49800 |
Sunitinib Malate has very good oral bioavailability, is highly efficacious in a number of preclinical tumor models, and is well tolerated at efficacious doses. Sunitinib malate is an inhibitor used in the treatment of advanced renal cell carcinoma and gastrointestinal stromal tumors.
Sunitinib works by preventing cytopathic effect from getting the blood and nutrients they need to grow. Clinical trials have shown that the drug slows the growth rate of gastrointestinal stromal serious diseases and reduces the size of renal-cell diseases. Sunitinib, a malate , is the first novel targeted drug that can selectively target multiple tyrosine kinase receptors.
){kind=link}